201,918 results on '"business"'
Search Results
2. Scienture Holdings, Inc. Files SEC Form 8-K, Current Report: (Oct. 11, 2024)
3. Renovaro Inc. Files SEC Form 8-K, Current Report: (Oct. 16, 2024)
4. Walgreens Boots Alliance, Inc. Files SEC Form 8-K, Current Report: (Oct. 15, 2024)
5. Zoetis Inc. Files SEC Form 8-K, Current Report: (Oct. 10, 2024)
6. Walgreens Boots Alliance, Inc. Files SEC Form 10-K, Annual Report [Section 13 And 15(D), Not S-k Item 405]: (Oct. 15, 2024)
7. Vireo Growth Inc. Files SEC Form 8-K, Current Report: (Oct. 15, 2024)
8. Vireo Growth Inc. Files SEC Form S-3/A, Registration Statement Under Securities Act of 1933: (Oct. 16, 2024)
9. Virpax Pharmaceuticals, Inc. Files SEC Form 10-K/A, Annual Report [Section 13 And 15(D), Not S-k Item 405]: (Oct. 10, 2024)
10. Vaccinex, Inc. Files SEC Form S-3, Registration Statement Under Securities Act of 1933: (Oct. 16, 2024)
11. Vireo Growth Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Oct. 11, 2024)
12. Verrica Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Oct. 11, 2024)
13. Vireo Growth Inc. Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities: (Oct. 15, 2024)
14. Upstream Bio, Inc. Files SEC Form S-8, Securities To Be Offered To Employees in Employee Benefit Plans: (Oct. 11, 2024)
15. Upstream Bio, Inc. Files SEC Form EFFECT, Notice of Effectiveness: (Oct. 11, 2024)
16. Upstream Bio, Inc. Files SEC Form 8-K, Current Report: (Oct. 15, 2024)
17. Upstream Bio, Inc. Files SEC Form S-1MEF, Registration Adding Securities To Prior Form S-1 Registration [Rule 462(B)]: (Oct. 10, 2024)
18. Upstream Bio, Inc. Files SEC Form CERT, Certification By An Exchange Approving Securities For Listing: (Oct. 10, 2024)
19. Upstream Bio, Inc. Files SEC Form 424B4, Prospectus [Rule 424(B)(4)]: (Oct. 11, 2024)
20. Universe Pharmaceuticals Inc. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Oct. 10, 2024)
21. Tonix Pharmaceuticals Holding Corp. Files SEC Form SC 13G/A, Statement of Beneficial Ownership By Certain Investors: (Oct. 16, 2024)
22. Upstream Bio, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Oct. 15, 2024)
23. Tonix Pharmaceuticals Holding Corp. Files SEC Form 8-K, Current Report: (Oct. 16, 2024)
24. Traws Pharma, Inc. Files SEC Form DEF 14A, Other Definitive Proxy Statements: (Oct. 11, 2024)
25. Uniqure N.V. Files SEC Form 8-K, Current Report: (Oct. 15, 2024)
26. Tilray Brands, Inc. Files SEC Form 8-K, Current Report: (Oct. 10, 2024)
27. Synaptogenix, Inc. Files SEC Form S-3, Registration Statement Under Securities Act of 1933: (Oct. 10, 2024)
28. Talphera, Inc. Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities: (Oct. 10, 2024)
29. Tilray Brands, Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)]: (Oct. 10, 2024)
30. Synergy Chc Corp. Files SEC Form S-1/A, General Form For Registration of Securities Under The Securities Act of 1933: (Oct. 15, 2024)
31. Study Results from Gilead Sciences Inc. Update Understanding of Remdesivir (Remdesivir Effectiveness in Reducing the Risk of 30-day Readmission in Vulnerable Patients Hospitalized for COVID-19: A Retrospective US Cohort Study Using Propensity ...)
32. Survey reveals 8 in 10 Americans with ulcerative colitis struggle to find a public restroom during emergencies
33. Studies from Zoetis Inc. Yield New Data on Veterinary Science (Accuracy and validation of a point-of-care blood glucose monitoring system for use in horses)
34. Schrodinger, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Oct. 16, 2024)
35. Study Findings from Osaka University Broaden Understanding of Proinsulin (Heterologous Production of Corosolic Acid, a Phyto-insulin, In Agroinfiltrated Nicotiana Benthamiana Leaves)
36. Supernus Pharmaceuticals, Inc. Files SEC Form 8-K, Current Report: (Oct. 10, 2024)
37. Schrodinger, Inc. Files SEC Form 144, Report of Proposed Sale of Securities: (Oct. 15, 2024)
38. Perrigo New York, Inc. Files SEC Form CERT, Certification By An Exchange Approving Securities For Listing: (Oct. 10, 2024)
39. Smart For Life, Inc. Files SEC Form 8-K, Current Report: (Oct. 15, 2024)
40. Sanofi Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Oct. 11, 2024)
41. Research from Gansu Agricultural University in the Area of Botany Described (Comparative analysis of the physiological and transcriptomic profiles reveals alfalfa drought resistance mechanisms)
42. Rezolute, Inc. Files SEC Form PRE 14A, Other Preliminary Proxy Statements: (Oct. 10, 2024)
43. Research on Molecular Science Published by Researchers at Chinese Academy of Agricultural Sciences (Genome-Wide Identification, Phylogenetic, and Expression Analysis of Jasmonate ZIM-Domain Gene Family in * * Medicago Sativa* * L)
44. Quoin Pharmaceuticals, Ltd. Files SEC Form PRE 14A, Other Preliminary Proxy Statements: (Oct. 11, 2024)
45. Perrigo Ireland 10 Unlimited Co Files SEC Form CERT, Certification By An Exchange Approving Securities For Listing: (Oct. 10, 2024)
46. Renovaro Inc. Files SEC Form 10-K, Annual Report [Section 13 And 15(D), Not S-k Item 405]: (Oct. 10, 2024)
47. Qilian International Holding Group Ltd Files SEC Form SC 13D, General Statement of Acquisition of Beneficial Ownership: (Oct. 16, 2024)
48. Perrigo Mexico Investment Holdings, LLC Files SEC Form CERT, Certification By An Exchange Approving Securities For Listing: (Oct. 10, 2024)
49. Qilian International Holding Group Ltd Files SEC Form 6-K/A, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Oct. 10, 2024)
50. Report Summarizes Chemicals and Chemistry Study Findings from Shionogi & Company Co. Ltd. (Catalytic Activity of Triphenylphosphine for Electrophilic Aromatic Bromination Using n-bromosuccinimide and Process Safety Evaluation)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.